LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 13.87 | 27.76 | 1 | 604 | 0.0017 | -0.5265 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 13.87 | 27.76 | 810 | 604 | 1.3395 | 1.1359 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 13.87 | 27.76 | 565 | 604 | 0.9343 | 0.9697 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 13.87 | 27.76 | 1192 | 604 | 1.9712 | 1.3299 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 15.58 | 27.76 | 5 | 685 | 0.0073 | -0.3096 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 15.58 | 27.76 | 930 | 685 | 1.3565 | 1.1363 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 15.58 | 27.76 | 2 | 685 | 0.0029 | -0.4337 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 15.58 | 27.76 | 822 | 685 | 1.1990 | 1.0800 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 15.58 | 27.76 | 948 | 685 | 1.3828 | 1.1451 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 15.58 | 27.76 | 1194 | 685 | 1.7416 | 1.2548 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 17.28 | 27.76 | 7 | 838 | 0.0083 | -0.2443 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 17.28 | 27.76 | 793 | 838 | 0.9455 | 0.9773 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 17.28 | 27.76 | 3 | 838 | 0.0036 | -0.3640 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 17.28 | 27.76 | 770 | 838 | 0.9181 | 0.9655 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 17.28 | 27.76 | 1033 | 838 | 1.2316 | 1.0866 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 17.28 | 27.76 | 1147 | 838 | 1.3676 | 1.1315 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 18.98 | 27.76 | 11 | 941 | 0.0117 | -0.1665 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 18.98 | 27.76 | 747 | 941 | 0.7937 | 0.9111 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 18.98 | 27.76 | 3 | 941 | 0.0032 | -0.3545 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 18.98 | 27.76 | 751 | 941 | 0.7980 | 0.9132 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 18.98 | 27.76 | 1043 | 941 | 1.1082 | 1.0408 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 18.98 | 27.76 | 1134 | 941 | 1.2049 | 1.0747 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 20.68 | 27.76 | 7 | 1119 | 0.0063 | -0.2277 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 20.68 | 27.76 | 741 | 1119 | 0.6622 | 0.8513 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 20.68 | 27.76 | 3 | 1119 | 0.0027 | -0.3411 | MN20160318_Q01 | F14 |